(Q44837571)

6 December 2017

title

Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine (English)

1 reference

6 December 2017

1 reference

4

Donald F Smee

1 reference

6 December 2017

5

John D Morrey

1 reference

6 December 2017

Dale L Barnard

1

1 reference

6 December 2017

Valerie D Hubbard

2

1 reference

6 December 2017

Jared Burton

3

1 reference

6 December 2017

Michael J Otto

6

1 reference

6 December 2017

Robert W Sidwell

7

1 reference

6 December 2017

publication date

1 January 2004

1 reference

Antiviral Chemistry & Chemotherapy

6 December 2017

published in

1 reference

6 December 2017

volume

15

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

15-22

1 reference

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Coumarins and pyranocoumarins, potential novel pharmacophores for inhibition of measles virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Structural genomics of the SARS coronavirus: cloning, expression, crystallization and preliminary crystallographic study of the Nsp9 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Aetiology: Koch's postulates fulfilled for SARS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Inhibition of SARS-associated coronavirus infection and replication by RNA interference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Is traditional Chinese medicine useful in the treatment of SARS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Aminopeptidase N inhibitors and SARS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Mechanisms and enzymes involved in SARS coronavirus genome expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

mRNA cap-1 methyltransferase in the SARS genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Managing SARS amidst uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

The SARS-CoV S glycoprotein: expression and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500102

10.1177/095632020401500102

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference